Bal Pharma Share Price

Bal Pharma Share Price

NSE: BALPHARMA
|
Pharmaceuticals
|
S Cap
₹ 87.71
+₹2.06 (2.41%)
1D
Last updated 03 Sep, 2026, 15:56 IST

Bal Pharma Share Price Today

As of 3 Sep 2026, Bal Pharma share price is ₹87.71. The stock opened at ₹85.50, compared to its previous close of ₹85.65. During today's trading session, Bal Pharma share price moved in the range of ₹85.13 to ₹90.50, with an average price of ₹87.81 for the day. Looking at its last 52-week, the stock has touched a low of ₹60.00 and a high of ₹98.85. On the performance front, Bal Pharma share price has increased by 14.63% over the last six months and is down 5.47% on a year-on-year basis.

₹85.13
2.41% up today
₹90.50
1D LOW
1D HIGH

Bal Pharma Returns Calculator

Circuit
L
H
₹68.52
₹102.78
52-week
L
H
₹60.00
₹98.85

About Bal Pharma

Bal Pharma Share Price
ISIN
INE083D01012
Sector Market Cap
₹ 135.87 Cr

Bal Pharma Limited is a pharmaceutical company engaged in the manufacturing and selling of pharmaceutical products. The Company is engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients (API). It specializes in prescription drugs, generic & OTC products, intravenous infusion, and bulk actives. The Company offers a range of APIs including antihistamine, platelet inhibitor, anti-diabetic, anticonvulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, acne treatment, and others. It also offers a range of formulations covering dosage forms-tablets, capsules, syrups, suspensions, IV infusions, ophthalmics, creams and ointments to various semi-regulated markets. The API products are being exported to Japan, Australia, Spain, the United Kingdom, Canada, Nigeria, Iceland, Slovenia, Romania, Brazil, Pakistan, Germany, South Africa, Serbia, Taiwan, Malaysia, Thailand, among others.

Bal Pharma Financial Highlights

  • Revenue: Bal Pharma reported revenue of ₹313.59 crore in FY26 vs ₹305.28 crore in FY25. It showed an increase of 2.72% on a yearly basis.
  • Operating Profit: Bal Pharma reported an operating profit of ₹5.93 crore in FY26 vs ₹5.14 crore in FY25. It showed an increase of 15.37% on a year-on-year basis.
  • Net Profit: Bal Pharma reported a net profit of ₹6.32 crore in FY26 vs ₹7.24 crore in FY25. It showed a decrease of 12.71% on a yearly basis.

Bal Pharma Quarterly Result Highlights

  • Bal Pharma reported revenue of ₹89.06 crore in Jun 2026, compared with ₹83.84 crore in Mar 2026, representing an increase of 6.23% on a quarter-on-quarter (QoQ) basis.
  • Bal Pharma reported an operating profit of ₹1.14 crore in Jun 2026, compared with ₹3.22 crore in Mar 2026, representing a decrease of 64.60% on a quarter-on-quarter (QoQ) basis.
  • Bal Pharma reported a profit of ₹1.14 crore in Jun 2026, compared with ₹3.60 crore in Mar 2026, reflecting a decrease of 68.33% on a QoQ basis.
  • The earnings per share (EPS) of Bal Pharma stood at ₹4.54 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
50.86%
FII
0.15%
Other DII
0.00%
Retail and other
48.99%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.22%
Dec 20250.14%
Mar 20260.14%
Jun 20260.15%
Mkt Cap Cr
135.87
P/E
18.76
P/B
1.65
ROE
7.64%
D/E
1.48
ROCE
9.18%
Div. Yield
1.41%
EPS(TTM)
4.51
Turnover
0.85
EV/EBITDA
8.14
Net Margin
0.00%
Op. Margin
0.00%
ROA
1.93%
Quick Ratio
0.00
Curr. Ratio
2.27
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Bal Pharma has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Bal Pharma appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Bal Pharma earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,63,791.0038.285.5513.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,45,081.0083.7914.6215.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,90,351.0088.2922.6425.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,14,833.0025.004.2418.59%0.3117.35%237.300.09%0.3335.38
Cipla1,14,163.0034.023.3211.27%0.0014.95%423.360.92%0.4543.52
Laurus Labs1,00,660.0092.3218.9916.77%0.4016.14%97.200.11%0.6713.72
Lupin98,431.0017.734.3823.76%0.0424.88%659.000.84%0.57129.18
Dr. Reddy's Laboratories96,906.3030.442.5511.07%0.1812.54%377.950.69%0.4138.68
Mankind Pharma98,304.7047.546.0311.74%0.3413.13%396.980.04%0.4449.37
Aurobindo Pharma95,299.8025.682.529.25%0.1911.76%394.820.24%0.3841.58

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Bal Pharma Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹303.08₹339.22₹304.22₹281.21
Other Income₹2.20₹2.85₹0.94₹5.15
Total Revenue₹305.29₹342.07₹305.16₹286.37
Total Expenses₹300.15₹333.02₹300.41₹277.18
Profit Before Tax₹5.14₹9.05₹4.75₹9.18
Tax-₹2.10₹1.60₹2.13₹3.48
Profit After Tax₹7.24₹7.45₹2.62₹5.70
EPS - Basic₹4.54₹4.96₹1.67₹3.79
EPS - Diluted₹4.54₹4.96₹1.68₹3.79

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹5.14₹9.05₹4.75₹9.18
Income before WC changes₹29.88₹31.39₹26.49₹26.34
Change in Assets-₹11.84-₹3.06-₹65.63-₹21.12
Change in Liabilities₹4.35-₹0.98₹38.11₹22.78
Change in WC-₹7.49-₹4.04-₹27.53₹1.66
Cash flow from Operations₹20.32₹22.81-₹1.54₹26.80
Cash flow from Investing-₹14.92-₹18.89-₹22.18-₹9.48
Cash flow from Financing-₹7.84-₹1.21₹24.09-₹17.22
Total Cash Flow-₹2.44₹2.71₹0.37₹0.09
Cash (Start of the year)₹4.20₹1.49₹1.11₹1.02
Cash (End of the year)₹1.75₹4.20₹1.49₹1.11

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹100.82₹85.68₹85.02₹75.96
Current Assets₹234.87₹234.16₹228.16₹184.57
Total Assets₹335.69₹319.84₹313.17₹260.53
Current Liabilities₹219.50₹203.06₹209.33₹165.64
Net Current Asset₹15.37₹31.10₹18.82₹18.93
Non-Current Liabilities₹38.79₹44.81₹40.14₹36.40
Equity Capital₹77.40₹71.97₹63.70₹58.49
Total Equity & Liabilities₹335.69₹319.84₹313.17₹260.53

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹302.50₹338.54₹303.10₹280.37
Other Income₹2.15₹2.30₹2.19₹6.49
Total Revenue₹304.65₹340.84₹305.29₹286.86
Total Expenses₹298.91₹331.52₹296.74₹274.80
Profit Before Tax₹5.73₹9.32₹8.55₹12.06
Tax-₹2.07₹1.59₹2.42₹3.48
Profit After Tax₹7.80₹7.73₹6.13₹8.58
EPS - Basic₹4.89₹5.13₹3.90₹5.79
EPS - Diluted₹4.89₹5.13₹3.94₹5.67

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹5.73₹9.32₹8.55₹12.06
Income before WC changes₹30.34₹30.85₹27.40₹26.04
Change in Assets-₹12.58₹2.56-₹42.56-₹21.43
Change in Liabilities₹4.63-₹0.32₹21.04₹27.07
Change in WC-₹7.95₹2.23-₹21.52₹5.64
Cash flow from Operations₹20.31₹28.54₹5.38₹30.57
Cash flow from Investing-₹14.90-₹18.84-₹22.08-₹13.43
Cash flow from Financing-₹7.83-₹6.94₹17.12-₹17.22
Total Cash Flow-₹2.42₹2.76₹0.42-₹0.08
Cash (Start of the year)₹4.06₹1.30₹0.81₹0.89
Cash (End of the year)₹1.64₹4.06₹1.23₹0.81

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹102.91₹87.68₹77.75₹71.56
Current Assets₹247.65₹246.55₹269.95₹218.20
Total Assets₹350.56₹334.23₹347.70₹289.76
Current Liabilities₹213.46₹197.13₹212.15₹166.10
Net Current Asset₹34.19₹49.41₹57.80₹52.10
Non-Current Liabilities₹38.28₹44.25₹39.52₹36.34
Equity Capital₹98.82₹92.84₹96.03₹87.32
Total Equity & Liabilities₹350.56₹334.23₹347.70₹289.76
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
87.71
2255
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 2255
Buy orders: 0%
Sell orders: 100%
Bearish
1
Neutral
5
Bullish
2
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
48.88
Neutral
ATR (14)
2.81
Neutral
STOCH(9,6)
52.71
Neutral
STOCH RSI (14)
89.17
Bearish
ADX(9)
18.97
Bullish
UO(9)
35.04
Neutral
ROC(12)
0.76
Bullish
WillR(14)
-48.28
Neutral
Period
Simple value
Exponential vaue
5D
85.18
85.29
10D
85.25
85.42
20D
86.37
85.89
50D
85.26
85.5
100D
83.77
83.27
Volume trend — traded volume by day
3 Sep0L
2 Sep0L
1 Sep0L
31 Aug0L
28 Aug0L
27 Aug0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Bal Pharma Share Price
Bal Pharma
Pharmaceuticals
Add Stock
Add Another

Bal Pharma Share Price FAQs

Bal Pharma share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837